Activation of anti-Trypanosoma cruzi drugs to genotoxic metabolites promoted by mammalian microsomal enzymes
- 1 April 1988
- journal article
- research article
- Published by Elsevier in Mutation Research/Genetic Toxicology
- Vol. 204 (4) , 577-583
- https://doi.org/10.1016/0165-1218(88)90060-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Mutagenicity of CL 64 855, a potent anti-Trypanosoma cruzi drugMutation Research/Genetic Toxicology, 1986
- Mutagenicity of anti-trypanosomal drug, Ro 7-1051, in Escherichia coli.The Japanese Journal of Genetics, 1983
- Type I nitroreductases of Escherichia coliCanadian Journal of Microbiology, 1981
- Mutagenicity of nitrofuran drugs in bacterial systemsFolia Microbiologica, 1980
- Mutagenicity of nifurtimox in Escherichia coliMutation Research/Genetic Toxicology, 1980
- Generation of superoxide anion and hydrogen peroxide induced by nifurtimox in Trypanosoma cruziArchives of Biochemistry and Biophysics, 1979
- Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity testMutation Research/Environmental Mutagenesis and Related Subjects, 1975
- Nitrofurazone-reducing enzymes in E. coli and their role in drug activation in vivoCanadian Journal of Microbiology, 1975
- On the mutagenicity of nitrofuransMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1974
- “Activation” of nitrofurazone in animal tissuesBiochemical Pharmacology, 1971